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ABSTRACT: The circadian clock is a critical regulator of immune function. We recently highlighted a role for the circadian
clockinamousemodelofpulmonaryinflammation.TheepithelialclockproteinBmal1wasrequiredtoregulateneutrophil
recruitment in response to inflammatory challenge. Bmal1 regulated glucocorticoid receptor (GR) recruitment to the neu-
trophil chemokine,CXCchemokine ligand5 (CXCL5), providing a candidatemechanism.Wenowshow that clock control
of pulmonary neutrophilia persists without rhythmic glucocorticoid availability. Epithelial GR-null mice had elevated
expression of proinflammatory chemokines in the lung under homeostatic conditions. However, deletion of GR in the
bronchialepitheliumblockedrhythmicCXCL5production,identifyingGRasrequiredtoconfercircadiancontroltoCXCL5.
Surprisingly, rhythmic pulmonary neutrophilia persisted, despite nonrhythmic CXCL5 responses, indicating additional
circadian control mechanisms. Deletion of GR in myeloid cells alone did not prevent circadian variation in pulmonary
neutrophilia and showed reduced neutrophilic inflammation in response to dexamethasone treatment. These new data
show GR is required to confer circadian control to some inflammatory chemokines, but that this alone is insufficient to
prevent circadian control of neutrophilic inflammation in response to inhaled LPS, with additional control mechanisms
arising in themyeloid cell lineage.—Ince, L.M., Zhang,Z., Beesley, S.,Vonslow,R.M., Saer, B.R.,Matthews, L.C., Begley,
N., Gibbs, J. E., Ray, D. W., Loudon, A. S. I. Circadian variation in pulmonary inflammatory responses is independent of
rhythmic glucocorticoid signaling in airway epithelial cells. FASEB J. 33, 126–139 (2019). www.fasebj.org
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Glucocorticoids (Gcs) are potent immune suppressors.
They regulate cytokine and chemokine expression during
inflammation, leading to decreased leukocyte infiltration
to affected tissues (1–4). Endogenous Gcs are secreted in a
highly rhythmic manner (5) with pulses every 1–2 h (an
ultradian rhythm) and amajor oscillation period of;24 h
(a circadian rhythm). This rhythmic signal can also entrain
rhythms in peripheral tissues, synchronizing themolecular
clock present in cells throughout the body (6). RhythmicGc
signaling may be integral to transcriptional oscillations in
peripheral tissues and has been shown to regulate a large
proportionof the liver transcriptome (7).However, very few
studies have directly examined the importance of rhythmic
Gc signals for coordinating rhythmic physiologic processes.
It is known that theGc receptor (GR, encodedbyNr3c1)
can directly interact with core clock components CRY1
and CRY2 to modulate GR-mediated transactivation, but
that does not interfere with the repressive effects of Gc
treatment upon inflammatoryNF-kB target genes (8, 9). In
contrast, Gc effects on inflammatory gene expression can
be strongly modulated by the clock component REV-
ERBa (Nr1d1) because REV-ERBa presence decreases the
stability of GR and leads to an inverse relationship of
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nuclear localization between the 2 proteins (10). REV-
ERBa may, therefore, be a candidate gatekeeper of GR
nuclear entry and, thus, regulate GR function according to
time of day. Furthermore, GR function may also be mod-
ified by posttranslational modifications of the receptor
itself. GR possesses multiple sites for phosphorylation,
acetylation, and SUMOylation, along with ubiquitination
(reviewed in Kadmiel and Cidlowski 11). The BMAL1/
CLOCK complex of the core clock itself can modify GR
activity in this way, via CLOCK-mediated acetylation of
the hinge region (12, 13).
The lung is acutely sensitive to both the immune-
modulatory and time-keeping effects of Gc signaling,
exhibiting oscillations in gene expression, which can be
shiftedbymanipulating theconcentrationsofcirculatingGcs
over time (14). We have previously reported a strong time-
of-dayvariation inpulmonary responsiveness toLPS,which
dependsonan intact circadianclock inairwayepithelial cells
(3). Rhythmic expressionof theGc-repressedgeneCxcl5 and
its subsequent secretion is a key epithelial cell signal regu-
lating neutrophil influx from blood to lung. Disruption of
Gc signaling via adrenalectomy (removing the endogenous
ligand) blunts these oscillations, indicating a role for Gcs in
driving the rhythmic phenotype observed. We, therefore,
proposed that rhythmic Gc signaling in airway epithelial
cells is critical for generating rhythms in pulmonary LPS
response. This was tested by manipulating Gc signaling
pharmacologically (via corticosteroneclamp)andgenetically
in key target cells (airway epithelium and macrophages).
MATERIALS AND METHODS
Mice
Airway epithelium-specific GR-knockout mice were generated
by crossingmice expressing a codon-improved Cre recombinase
driven by the Scgb1a1 [which encodes the club cell secretory
protein (CCSP)] promoter (15), referred to herein as CcspiCre/+,
with GR-floxed mice (B6.129P2-Nr3c1tm2Gsc/Ieg (16), hence-
forth referred to asGRflox/flox, obtained from theEuropeanMutant
Mouse Archive; Infrafrontier Research Infrastructure, Munich,
Germany). Integrationof theCresequencewasexaminedbyPCR
on genomic DNA (forward primer 59‑AGATGCCAGGAC-
ATCAGGAACCTG‑39; reverse primer 59‑ATCAGCCACACC-
AGACACAGAGATC‑39). Macrophage-specific GR knockout
mice were generated by crossing LysMCre/+ mice (17) with the
GRflox/floxmice. Integration of the Cre sequence was examined by
PCR on genomic DNA (forward primer: 59‑CTTGGGCTGCC-
AGAATTTCTC‑39, reverse primer: 59‑CCCAGAAATGCCAG-
ATTACG‑39). All mice were onC57BL/6J background andwere
subsequently crossed with mice on an mPer2Luc background to
facilitate bioluminescent imaging studies (18). Thus, the genet-
ically modified strains used were GRflox/floxmPer2LucCcspicre,
henceforth known as Ccsp-GR2/2 (epithelial GR knockout),
GRflox/floxmPer2LucLysMcre, henceforth known as LysM-GR2/2
(myeloid GR knockout), and the common littermate controls
GRflox/floxmPer2Luc, henceforth known as GRWT (GR wild type).
Mice were housed in 12-h light/dark cycles with food and
water ad libitum. Additional changes to lighting schedules are
detailed in Supplemental Fig. 1. All experimentswere performed
in accordance with the Animals (Scientific Procedures) Act of
1986 (United Kingdom). In each experiment, we used age-
matched, adult,malemice tominimizevariability; specificdetails
are given in figure legends and individual methods.
Corticosterone clamp
C57BL/6J mice were bought from Envigo (Huntingdon, United
Kingdom) at 8wkon arrival andallowed to settle for 1wkbefore
surgery. All surgerywas completed under isoflurane anesthesia.
After shaving the nape of the neck, a small incision was made in
the skin to form a pocket in which a pellet (21-d release cortico-
sterone pellet; Innovative Research of America, Sarasota, FL,
USA) was implanted. Pellets of 2.5, 5, or 7.5 mg (or vehicle con-
trol)wereused todetermineanappropriatedose, and2.5mgwas
used in experiments thereafter. The incision was sutured and
mice were monitored for at least 1 wk before any further exper-
iments. At the time of LPS challenge, mice were 11–12 wk old.
Corticosterone ELISA
To measure circulating levels of corticosterone, blood samples
were collected via tail tipping at zeitgeber time (ZT) 0 (lights on),
ZT6 (midday), ZT12 (lights off), and ZT18 (midnight). Serum
corticosterone levels were measured by an ELISA Kit, according
to the manufacturer’s instructions (ADI-900-097; Enzo Life Sci-
ences Inc., Farmingdale, NY, USA). Briefly, a 5-ml sample was
mixed with an equal volume of steroid-displacement reagent.
After 5 min of incubation, 190 ml of elution buffer was added to
themixture; 100ml of thedilutedsampleswereadded toa96-well
plate, and standard protocols were then followed. Plates were
read at 405 nm on a plate reader (BioTek Instruments,Winooski,
VT, USA). Sample concentrationwas calculated from a standard
curve fit to asemilogstandardplot inExcel (Microsoft,Redmond,
WA, USA).
Nebulized LPS treatments
This procedurewas performed as previously described byGibbs
et al. (3), in constantdarkness to investigate the contributionof the
endogenous pacemaker and avoid any potential masking or
confounding effects of light. Briefly, after 24 h in constant dark-
ness, mice (median age, 12 wk) were exposed to nebulized LPS
(2 mg/ml, isolated from Escherichia coli 0127:B8, L3129; Milli-
poreSigma, Burlington, MA, USA) for 20 min in an acrylic
chamber. Mice were euthanized 5 h later with i.p. pentobarbital.
Lungs were lavaged with 1 ml bronchoalveolar lavage (BAL)
fluid (10 mM EDTA in PBS) from tracheal cannulae. After cen-
trifugation at 500 g for 5 min, BAL supernatant was stored at
280°C for protein concentration and ELISA measurement,
whereas cell pellets were resuspended for a total cell count
and flow cytometry. In some experiments, dexamethasone
(Dex; 1 mg/kg, D2519; MilliporeSigma) or saline vehicle was
administered intraperitoneally 1 h before LPS challenge
(Supplemental Fig. 1).
BAL cell analysis
Cell counts were obtained with a NucleoCounter NC-250 (che-
mometec, Lillerød,Denmark) total cell andviability assays onA8
slides. For flow cytometry, after blocking with anti-CD16/32
antibody (1:100, clone 93, 14-0161-86; Thermo Fisher Scientific,
Waltham, MA, USA), cells were stained with anti-CD45 pacific
blue (1:100, clone 30-F11, MCD4528; Thermo Fisher Scientific),
anti-CD11c APC (1:200, clone N418, 17-0114-82; Thermo Fisher
Scientific), and anti-Ly6G Alexa488 (1:200, clone RB6-8C5,
53-5931-82; Thermo Fisher Scientific) antibodies. Acquisition
was performed with an LSR II machine (BD Biosciences,
Franklin Lakes, NJ, USA), with $5000 CD45+ cells collected/
sample. FlowJo software v.10 (Tree Star, Ashland, OR, USA)
was used for analysis. BALmacrophages and neutrophils were
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defined as CD45+CD11c+Ly6G2 and CD45+CD11c2Ly6G+,
respectively, and their concentrations were calculated by
multiplying the percentage observed by the total cell count.
BAL protein concentrations
BALtotalprotein concentrationwasmeasuredbyaBicinchoninic
Acid (BCA)ProteinAssayKit (BCA1andB9643;MilliporeSigma).
ELISAmeasurements were performedwith R&D Systems brand
ELISA kits (CXCL5: DY443, TNF-a: DY410, and IL6: DY406; Bio-
Techne, Minneapolis, MN, USA).
GR in situ hybridization
Lungs were inflated with a 50% OCT/50% PBS solution to
maintain structure, snap frozen on dry ice, and stored at280°C
before cryosectioning. Twelve-micrometer sections were cut us-
ing a CM3050 cryostat (Leica Biosystems, Wetzlar, Germany)
treated with RNaseZap (Thermo Fisher Scientific) to minimize
RNAdegradation.GR in situhybridizationwasperformedusing
prGR9 plasmid (a kind gift from Professor Karen Chapman,
University of Edinburgh, Edinburgh, United Kingdom), as pre-
viously described by Gibbs et al. (3). Relative intensity from
several lungsectionswasquantified in ImageJ software (National
Institutes of Health, Bethesda, MD, USA).
Immunohistology protocols
Lungs from naive mice were inflated with freshly prepared 4%
paraformaldehyde and fixed overnight at 4°C. Tissue samples
were then processed and embedded in paraffin wax before cut-
ting 5-mm sections via microtome. GR immunofluorescence
staining was performed by routine staining procedures, in-
cluding antigen retrieval in sodium citrate buffer. Primary anti-
body (rabbit anti-GR, M-20; Santa Cruz Biotechnology, Dallas,
TX, USA) was used at 1:100 dilution in TNB buffer (TSA kit with
tetramethylrhodamine; PerkinElmer, Waltham, MA, USA), fol-
lowed by biotinylated goat anti-rabbit at 1:500, streptavidin–
horseradish peroxidase at 1:200, and tyramide substrate at 1:50.
Mounting medium contained DAPI as a counterstain (Vector
Laboratories, Burlingame, CA, USA).
Bioluminescence imaging and photomultiplier
tube experiments
Precision-cut lung sections were prepared via vibratome (Inte-
grasection 7550MM; Campden Instruments, Loughborough,
United Kingdom) with a thickness of 275mm (19). Sections were
placed on cell culture inserts within 35-mm, glass-bottomed
dishes containing1ml of luciferin recordingmedium, sealed by a
glass coverslip. Photon count was recorded in 1 h time bins with
an LV200 luminescence microscopy system (Olympus, Tokyo,
Japan), as previouslydescribed byGibbs et al. (3). Bronchiole and
parenchyma regions were selected and analyzed with ImageJ
software. Bioluminescence frommacrophageswas recordedby a
photomultiplier tube system, as previously described by Gibbs
et al. (20). Data was detrended with a 24-h moving average and
plotted as relative bioluminescence (photons/min). Phase change
was calculated as the timing of the fourth peak of treated samples
relative to the fourth peak of untreated samples (19). To test re-
sponses to ligands of theGc andmineralocorticoid receptor (MR),
we used corticosterone (100 nM; MilliporeSigma), RU486 (mife-
pristone, 1mM;MilliporeSigma),Dex (200nM;MilliporeSigma), 2
syntheticnonsteroidal compounds [67and69 (21)], usedat10nM,
a kind gift from Dr. Stuart Farrow, (GlaxoSmithKline, Brentford,
United Kingdom), and an agonist of the MR spironolactone
(1 mM; MilliporeSigma).
Laser-capture microdissection
Mouse distal bronchiolar epithelial cell microdissection was
performedaspreviouslydescribedbyBetsuyakuandSenior (22).
Approximately 0.8 ml of 50% v/v of OCT/PBS solution was
installed via tracheal cannula into each mouse before samples
were frozen in OCT on dry ice and stored at 280°C. Samples
were cut into 7-mm sections onto PEN membrane slides
(11600288; Leica Microsystems, Wetzlar, Germany) using a
cryostat. After serial dehydration in ethanol solutions (50, 70, 90,
100, and 100%, 30 s each), slides were allowed to air-dry for;2
min before being dissected under an LMD6500 microdissection
system (LeicaMicrosystems).Distal bronchiolar epitheliumup to
200 nm from the opening to alveolar areas was collected.
Time-serial airway epithelial cell harvest
Ccsp-GR2/2 andGRWTmice (median age, 12wk)were housed in
constant darkness for 24 h before lung collection (every 4 h for
44h, 1mouse/genotype/timepoint). Frozen lungswereused for
laser capture to harvest airway epithelial cell RNA, as described
above. Then, core circadian clock genes were measured by
quantitative PCR (qPCR).
qPCR
For qPCR, proprietary assays were used for Cxcl5 (Mm00436451_
g1), Cxcl15 (Mm00441263_m1), and GR (Mm00433832_m1) (all
Applied Biosystems brand; Thermo Fisher Scientific). Circadian
clock gene primers were as follows: Bmal1 forward, 59‑CCGTG-
CTAAGGATGGCTGTT‑39, reverse 59‑TCTGTGTATGGGTTGGT-
GGC‑39 (SYBR green-based assay); Nr1d1 forward 59‑ACGA-
CCCTGGACTCCAATAA‑39, reverse 59‑CCATTGGAGCTGTCAC-
TGTAGA‑39, universal probe 52; Nr1d2 forward 59‑ACAGAAA-
TAGTTACCTGTGCAACACT‑39, reverse 59‑GACTTGCTCATA-
GGACACACCA‑39, universal probe 88; Per2 forward 59‑TCCGAG-
TATATCGTGAAGAACG‑39, reverse 59‑CAGGATCTTCCCAG-
AAACCA‑39, universal probe 5; Dbp forward 59‑CTTTTGACCC-
TCGGAGACAC‑39, reverse 59‑CCGGCTCCAGTACTTCTCAT‑39,
universal probe 82; Cry1 forward 59‑ATCGTGCGCATTTCACA-
TAC‑39, reverse 59‑TCCGCCATTGAGTTCTATGAT‑39, universal
probe 85 (all F. Hoffmann-La Roche, Basel, Switzerland). 18s expres-
sion was used as an internal control (forward 59‑CTCAACA-
CGGGAAACCTCAC‑39, reverse 59‑CGCTCCACCAACTAAG-
AACG‑39 and universal probe 77 (F. Hoffmann-La Roche). Samples
were run in aStepOnePlusReal-TimePCRSystemmachine (Thermo
Fisher Scientific) and quantified by the cycle threshold (22DDCt)
method.
Nanostring
Nebulized LPS challenge was performed in Ccsp-GR2/2 and
control GRWT mice, as described above, at circadian time (CT)
0 (the start of the subjective day; Supplemental Fig. 1),with either
Dexor saline pretreatment. Right lung lobeswere snap-frozen on
dry ice forRNAextraction.AfterRNApurification (RNeasyMini
Kit; Qiagen,Hilden, Germany), 5 samples/groupwere analyzed
with the nCounter Mouse Inflammation v.2 Assay (XT-CSO-
MIN2-12; Nanostring Technologies, Seattle, WA, USA). Gene
counts were normalized using nSolver software (Nanostring
Technologies), and normalized reads were analyzed by 2-way
ANOVA, P-value–adjusted with a false-discovery rate of 0.05.
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Hierarchical clustering was performed in genes showing signif-
icant drug effects with Morpheus software (https://software.
broadinstitute.org/morpheus/).
RNA sequencing
RNA was extracted with the PicoPure RNA Isolation Kit
(Thermo Fisher Scientific), with RNA integrity checked with the
RNA6000PicoKit (AgilentTechnologies,SantaClara,CA,USA);
100 ng/sample (RNA integrity number,$6) was used for RNA
sequencing. The library was constructed with TruSeq v.3 Kit
(Illumina, San Diego, CA, USA) by the low-input method after
poly(A) selection of mRNA. After filtering and mapping, differ-
entially expressed geneswere called usingDEseq2 software (23).
Lung digestion and macrophage sorting
Mouse lungs were harvested into ice-cold Rosewell Park Me-
morial Institute (RPMI) 1640mediumandminced into finepieces
usingscissorsbeforedigestion in1mlLiberaseTM(0.156mg/ml;
F. Hoffman-La Roche) with 0.01 mg/ml DNase (F. Hoffman-La
Roche) for30minat roomtemperature.The reactionwas stopped
with an equal volume of 5 mM EDTA solution. The resulting
solutionwas applied onto a 70-mmcell strainer, and tissue pieces
were ground with a syringe head. For lung tissue macrophages,
near-infrared, fixable, live/dead stain (1:1000, L10119; Thermo
Fisher Scientific), anti-CD45 (as previously described), anti-
Siglec-F phycoerythrin (1:200, BD Pharmingen brand clone E50-
2440, 552126; BD Bioscience), and anti-CD11c (as previously
described) antibodies were used. Macrophages were defined as
CD45+Siglec-F+Cd11c+.
Peritoneal macrophage isolation
Peritoneal macrophages were isolated, as previously described
byGibbs et al. (20). Cellswere spun, resuspended inDMEMwith
10% fetal bovine serum, and left to attach for 1–2 h on tissue
culture–grade Petri dishes. Cells were then washed with PBS,
and attached cells were used as macrophages.
Western blot
GR Western blot was performed with 20 mg peritoneal macro-
phage protein lysate, obtained with Tissue Protein Extraction
Reagent (T-PER; Thermo Fisher Scientific) and quantified by
BCA assay (MilliporeSigma). Primary antibodies were GR
(1:1000, cloneM-20, sc-1004; Santa Cruz Biotechnology) and
b-tubulin (1:10,000, clone AA2, 05-661; MilliporeSigma).
Secondary antibodies were goat anti-rabbit IRDye 800CW
and goat anti-mouse IRDye 680RD (926-32211 and 926-
68070, 1:10,000 dilution for both; Li-Cor Biosciences, Lin-
coln, NE, USA). The membrane was scanned with Odyssey
CLx (Li-Cor Biosciences).
Statistics
Statistical analysis was performed with Prism software v.6
(GraphPadSoftware,La Jolla,CA,USA).Results arepresentedas
means 6 SE, unless otherwise stated. Comparisons of 2 groups
were performed with the Students’ t test, and 1-way ANOVA
with Tukey’s correctionwas used to comparemultiple groups as
appropriate. Where multiple variables were investigated, anal-
ysis was performed via 2-way ANOVA with Sidak’s multiple
comparisons test. In some cases (detailed in figure legends),
outlier analysiswasperformedwith theGrubbs’ test, andoutliers
removed before further analysis.
RESULTS
Rhythmic circulating Gcs are not required
for time-of-day variation in pulmonary
LPS responses
In mice, adrenalectomy only partially ablates the endog-
enous rhythm of corticosteroid because a residual, low-
amplitude oscillation persists (3). To test the importance of
circulating corticosterone as a timing signal, C57BL/6J
mice were implanted with slow-release corticosterone
(“clamp”), which, via feedback repression, eliminates the
rhythmic secretion of endogenous Gc. Serum corticoste-
rone concentration was measured 1 wk afterward at 6
different time points for animals housed in light/dark
cycles (ZT), where ZT0 is lights on, and ZT12 is lights off;
sampling times were ZT0, 4, 8 12, 16, and 20). We
employed a range of doses, fromwhichwe selected a dose
(2.5mg implant) that elicited a flat, unchanging, Gc profile
and was midpoint between the peak and trough of the
endogenous signal of unimplanted animals (Fig. 1A and
see Supplemental Fig. 2A for individual plots by dose).
Based on this “midpoint” dose, we treated clamped and
controlmicewithnebulizedLPSat4 timepoints (CT0,startof
subjective day; CT6, middle of subjective day; CT12, start of
subjective night; and CT18, middle of subjective night), with
BAL fluid collected 5 h later to analyze leukocyte infiltration
and CXCL5 concentration. Corticosterone concentrations
showed significant time-of-day variation in controlmice, but
no temporal variation was observed in clamped animals
(Supplemental Fig. 2B). We observed strong rhythmic neu-
trophil infiltration in control mice, as previously reported by
Gibbs et al. (3), and also in clamped mice, with similar am-
plitudeandphasing.Wehavepreviouslydescribedcircadian
amplitude changes of a key pulmonary chemokine CXCL5
involved in rhythmic inflammatory responses (3); this
showed robust circadian changes in both groups of animals
(Fig. 1B,C). BecauseGcs are known to act as potent resetting
agents for the circadian clock, we tested whether the clamp
procedure altered expression of underlying circadian clock
gene expression inwhole lung. Therewas a significant effect
of time on expression, but the phase and amplitude of ex-
pression was unaltered by the treatment (Fig. 1D).
GR deletion in airway epithelium disrupts
Dex-induced synchronization in the
bronchioles but not the parenchyma
As loss of the circadian rhythm in serum corticosterone
had no effect on circadian control of pulmonary in-
flammation, we next sought to examine the role of its re-
ceptors. Corticosteroids bind both the MR and GR with
equal affinity. We, thus, studied which receptor had a
dominant effect in mediating Gc signaling to the pulmo-
nary circadian oscillator. For this, we employed ectopic
lungslicesderived fromPER2::LUCreportermice (18) and
monitored them using whole-field bioluminescence (19).
GLUCOCORTICOIDS IN RHYTHMIC LUNG INFLAMMATION 129
Downloaded from www.fasebj.org by Univ of Leeds -Brotherton Library (129.11.22.236) on February 04, 2019. The FASEB Journal Vol. ${article.issue.getVolume()}, No. ${article.issue.getIssueNumber()}, pp. 126-139.
DCT0 CT6 CT12 CT18
0
2
4
6
8
Per2
Time of Challenge
R
.Q
.
CT0 CT6 CT12 CT18
0
1
2
3
4
Bmal1
Time of Challenge
R
.Q
.
R
.Q
.
0
5
10
15
Dbp
Time of Challenge
0
1
2
3
4
5
Cry1
Time of Challenge
R
.Q
.
0.0
0.5
1.0
1.5
2.0
2.5
Nr1d1
Time of Challenge
R
.Q
.
CT0 CT6 CT12 CT18 CT0 CT6 CT12 CT18 CT0 CT6 CT12 CT18
Control
CORT Clamp
A B
C
ZT0 ZT4 ZT8 ZT12 ZT16 ZT20
0
50
100
150
200
No Implant (Naive)
Empty Implant (Vehicle)
2.5mg CORT
5mg CORT
7.5mg CORT
Serum Corticosterone
C
or
tic
os
te
ro
ne
 (n
g/
m
l) N
o.
 o
f C
el
ls
 (x
10
5 /m
l)
B
A
L 
C
X
C
L5
 (n
g/
m
l)
N
o.
 o
f C
el
ls
 (x
10
5 /m
l)
B
A
L 
C
X
C
L5
 (n
g/
m
l)
Time of Collection
Time of Challenge Time of Challenge
Neutrophils CXCL5
Time of Challenge
Neutrophils
Time of Challenge
CXCL5
CT0 CT6 CT12 CT18
0
1
2
3
4
** *** *
CT0 CT6 CT12 CT18
0
1
2
3
4
*** ***
*
CT0 CT6 CT12 CT18
0
10
20
30
40
** *** **
CT0 CT6 CT12 CT18
0
5
10
15
20
25
* ** ***
Figure 1. Time-of-day variation in pulmonary LPS response is retained despite corticosterone clamp. A) Dose–responses used to
establish optimal corticosterone (CORT) clamp concentration. Corticosterone concentration in serum samples from tail blood
taken at the indicated time points, n = 5–7. Analysis was performed by 2-way ANOVA with Sidak’s multiple comparisons test
between time points, and a signiﬁcant main effect of treatment was observed. Individual dose plots are shown in Supplemental
Fig. 2; a dose of 2.5 mg was used in subsequent experiments. B, C) Inﬂammatory measurements 5 h after nebulized LPS exposure
at the indicated time points. Neutrophil counts in BAL ﬂuid and BAL CXCL5 concentration in control animals (B) and CORT-
clamped animals (C), median age 12 wk, n = 4–6/group. Analysis using Grubbs’ test revealed 3 outliers in the CXCL5 results in C
(1 each from CT0, CT6, and CT18), which were removed before further analysis. Analysis was performed by 1-way ANOVA and
post hoc tests with Tukey’s correction. Asterisk denotes signiﬁcance from CT0 time point, except where indicated. D) mRNA
expression of a panel of clock genes in whole lung of CORT-clamped and control animals after LPS challenge. Analysis was
performed via 2-way ANOVA; all genes showed a signiﬁcant effect of time but no differences between treatments. Data represent
means 6 SE. *P , 0.05, **P , 0.01, ***P , 0.001, ****P , 0.0001.
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We treated explants with corticosterone at the peak of the
circadian cycle of PER2::LUC bioluminescence. Cortico-
sterone administration resulted in increased amplitude of
the oscillations, along with a phase change (Fig. 2A). We
next employed novel GR-specific, nonsteroidal ligands 67
and 69 (21), which are known not to have MR action and
are highly selective GR ligands. This revealed marked
PER2::LUC resetting responses, which were blocked by
the GR antagonist RU486 (Fig. 2B, C). In contrast, the MR
antagonist spironolactone did not phase shift the PER2::
LUC oscillation and did not block the action of Gcs (Fig.
2D). Collectively, thesedata clearlydemonstrate thatGR is
the primary receptor involved in synchronization of the
circadian clock by endogenous Gcs in the lung.
Having established that, we next addressed the role
of the GR in pulmonary airway epithelial cells in mediat-
ing inflammatory responses, and generated a transgenic
mouse line that lacked GR in the airway epithelium (Ccsp-
GR2/2). Mice were born with expected Mendelian ratios
and survived into adulthood without apparent health is-
sues, and no apparent pulmonary morphologic changes
were observed. Using immunohistochemistry, we stained
for pulmonary GR expression, which revealed a loss of
expression specific to the bronchial epithelium, but no ob-
vious alteration in expression in adjacent parenchymal
structures (Fig.3A).Additionally,wecheckedexpressionof
the transcript in tissue sections using in situ hybridization,
which also revealed a clear loss of expression in conducting
airways (Fig. 3B). Thus, the Ccsp-GR2/2 construct effec-
tively targets those cells in the lung. Histologic analysis of
lung sections revealed no obvious morphologic or de-
velopmental differences.
To examine the effects of GR loss upon circadian
rhythmicity of the lung, the strain was then bred onto the
mPer2Luc background (18). Lung sections from these mice
were harvested and tested for responsiveness to synchro-
nization by the GR agonist Dex. We recorded luciferase
activitywithabioluminescence camera to compare signals
from bronchiolar and parenchymal regions (Fig. 3C and
Supplemental Videos 1 and 2). Tissues were exposed to
recording medium (time 0) and, when dampened to a
nonrhythmic state, treated with Dex. This had a powerful
resetting effect onPER2::LUCexpression in bothbronchial
and parenchymal regions in GRWT mice. In contrast, Dex
did not reset bronchiolar tissues derived fromCcsp-GR2/2
animals, but we did observe robust resetting responses in
adjacent parenchymal tissues (Fig. 3C). Thus, the effect of
GR targeting is specific to cell typewith in the ectopic lung
slice. Analysis of whole-lung tissue from GRWT and Ccsp-
GR2/2mice showed no significant effect of loss of GR on
overall expression of Bmal1, Per2, and Nr1d1/2 (Fig. 3D).
We next assessed the potential effect of such targeting
on the operation of the circadian gene complex within
GR-targeted cells. As gene expression in whole lung may
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Figure 2. Endogenous Gcs act through GR to modulate lung rhythmicity. A) Lung slices were taken from PER2::LUC mice and
bioluminescence was recorded before and after treatment with Cort (100 nM; arrow denotes treatment time). DMSO was used as
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RU486 (1 mM; B) or GSK69 (10 nM) and RU486 (C); data are representative of 3–7 experiments. D) Sections treated with Cort
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hoc tests with Tukey’s correction, n = 3–7. Data represent means 6 SE. ****P , 0.0001 compared with DMSO control.
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mask critical changes in airway epithelial cells, we
employed laser-capture microscopy to harvest airway
epithelial cells. These were collected from mice free-
running indarkness every 4 h for 44 h to produce a 2-cycle
time series in airway epithelial cells. This revealed robust
oscillations inmultiple components of the circadian clock.
Although an effect of genotype was observed upon Dbp
and Nr1d1, with Ccsp-GR2/2 mice showing elevated ex-
pression at the peaks of the cycle, that did not affect ex-
pression of their target genes Per2, Cry1, and Bmal1,
respectively (Supplemental Fig. 3), suggesting these mi-
nor amplitudedifferences lack significant functional effect
on the core clockwork. Thus, Gc-mediated resetting of the
circadian clockwork depends critically on GR, and not
MR, in target cells, but loss of GR does not affect free-
running endogenous oscillations of the circadian clock
gene complex in the targeted cells.
Deletion of GR in airway epithelium
disrupts CXCL5 rhythmicity but not
rhythmic neutrophilia
We have previously identified rhythmic GR binding to the
Cxcl5 promoter in lung as a key component in conferring
time-of-day changes in inflammatory responses, and this
was abolishedwhen the circadian clock element Bmal1was
disrupted inpulmonary epithelial cells (3). To test the role of
GR, we exposed Ccsp-GR2/2mice to nebulized LPS at CT0
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over multiple days from GRWT (left) and Ccsp-GR2/2 (right) lung sections. Dex was administered at the indicated time (arrow). Plot is
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andCT12andassessed temporal variation in total leukocyte
numbers and neutrophil infiltration. This revealed marked
time-of-day effects, as previously reported inGibbs et al. (3),
but no effect of genotype (Fig. 4A). In contrast, chemokine
CXCL5 responses to LPS exhibited marked time-of-day
differences inGRWTmice, also compatiblewith theprevious
report (3), but this time-of-day gating was lost in the Ccsp-
GR2/2mice (Fig. 4B). Further,weobservednodifferences in
totalproteinconcentrationofBAL,abiomarker for epithelial
permeability. Inwhole lung, expressionpatterns of the clock
genes Bmal1, Per2, Cry1, Nr1d1, and Nr1d2 (Fig. 4C) and
inflammatory marker genes Tnfa and Il6 (Fig. 4D) in re-
sponse to LPS were unaltered in Ccsp-GR2/2mice.
Deletion of GR in airway epithelium does not
affect anti-inflammatory effects of Dex
Gcs are known to reduce neutrophil influx in response to
nebulizedLPS (3). To testwhetherGR in the epithelial cells
is required, Ccsp-GR2/2 and GRWT control mice were
compared at CT0 (the time of maximal neutrophil influx),
with or without pretreatment with Dex (1 mg/kg, i.p.).
Dex treatment significantly reduced total cell count and
neutrophil number in BAL for bothGRWT andCcsp-GR2/2
mice with no significant interactions between genotype
and treatment (Fig. 5A), but a post hoc analysis indicated
effects in GRWT animals. Analysis of gene expression in
lung homogenate showed a significant reduction in Cxcl5
expression after Dex in both groups but with markedly
elevated baseline expression in Ccsp-GR2/2 mice. Addi-
tionally,Dexalso suppressedknownGc target genesCxcl1
and Il6 in an equivalent manner (Fig. 5B) but had no effect
upon a panel of clock genes (Supplemental Fig. 4).
Equivalent experiments performed at CT12 (the time of
minimalneutrophil influx) showedno significant effects of
Dex or genotype upon cell influx or CXCL5 concentration
(Supplemental Fig. 5).
To extend assessment of potentialGR targets,weused an
inflammatorygeneexpressionarraypanel (nCounterMouse
Inflammation V2, XT-CSO-MIN2-12; Nanostring Technol-
ogies) covering 248 genes and tested Dex responses in LPS-
treated mice. Both trans-repression and trans-activation GR
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targets were represented in the array (e.g., Csf3, Il23a, Il1b,
and Retnla, Chil3l3, Tgfb3, respectively). Approximately one
half of the panel (114 genes) showed significant responses to
Dex (Supplemental Table 1). An unbiased, hierarchical
clustering protocol revealed major effects of Dex but little
effect of genotype (Supplemental Fig. 6). Strikingly, Cxcl5
was the marked exception and the only transcript with al-
tered responses in Ccsp-GR2/2 lung tissue (Fig. 5C and
Supplemental Table 1).
Time-of-day difference in pulmonary Cxcl5
and Cxcl15 expression is ablated in Ccsp-GR2/2
mice in steady-state conditions
Deletion of bronchial epithelial GR did not significantly
alter neutrophilia in lung. To assess wider potential effect,
we undertook RNA sequencing analysis of bronchial ep-
ithelium, collected by laser microdissection of lung sam-
ples frozen at ZT14, timed for 2 h after the endogenous
corticosterone peak; 111 differentially expressed genes
were found with a criteria of P , 0.01 and a fold change
$1.5 or #1.5, including Cxcl5, Cxcl1, and Cxcl15, which
were all increased in Ccsp-GR2/2 samples (Fig. 6A).
Gene-ontologyanalysis of theRNAsequencingdata set
revealed significant changes in inflammatory response
terms, as expected, along with lipid metabolic processes
and response to hypoxia (Table 1). However, those anal-
yses were performed under light/dark conditions, so we
tested whether similar effects were seen under true circa-
dian conditions of continuousdarkness.Here,wealso saw
a loss of circadian gating responses of Cxcl5 and Cxcl15 in
Ccsp-GR2/2mice (Fig. 6B).
Myeloid GR deletion does not alter circadian
variation in pulmonary LPS response or
Dex sensitivity
We next tested the role of myeloid cells as critical re-
sponders in LPS-induced inflammation. To target macro-
phage populations, we generated LysM-GR2/2 mice.
Successful deletion of GR was confirmed in protein from
peritoneal macrophages (Supplemental Fig. 7A) and also
in RNA from pulmonary macrophages, confirming that
GR was deleted in both BAL and tissue-resident mac-
rophage populations (Supplemental Fig. 7B). Although
cultured LysM-GR2/2 peritoneal macrophages were
circadian rhythmic, theywere no longer sensitive toDex-
induced resynchronization (Supplemental Fig. 7C).
To examine the effect of myeloid cell GR disruption
on time-of-day variation in pulmonary LPS responses,
LysM-GR2/2 mice were exposed to nebulized LPS at
CT0 and CT12. Time-of-day differences were observed
for total leukocyte counts and BAL neutrophils in both
LysM-GR2/2 and GRWT littermate control mice (Fig.
7A). In contrast, there was no time-of-day variation of
BAL CXCL5, and total protein concentration in BAL
was significantly elevated in LysM-GR2/2 mice (Fig.
7B), indicative of disrupted epithelial barrier function.
In addition, inflammatory cytokines IL-6 and TNF-a
were significantly increased (Fig. 7C).
Finally, to test whether myeloid cell GR mediated Dex
suppression of the pulmonary LPS responses, LysM-GR2/2
and control mice were treated with nebulized LPS at CT0
with or without Dex pretreatment (1 mg/kg, i.p.). Analysis
of the cellular content of BAL fluid showed retention ofDex
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sensitivity in LysM-GR2/2 animals, with comparably fewer
BAL cells after Dex treatment in both genotypes (Fig. 7D).
DISCUSSION
Gcs are very widely used to treat inflammatory diseases,
and natural, endogenous Gcs are the principal anti-
inflammatory response system in vivo (24). Despite such
widespread application, it remains unclear which are the
main target cells and how the response to Gc varies. En-
dogenousGcproduction is pulsatile,witha superimposed
circadian rhythm (25), but this aspect of physiology is not
considered in therapeuticdevelopmentor application.The
cross-coupling of Gc action to the circadian clock is ex-
tensive, with Gc serving as regulators of circadian clock
phase. In vitro application of Gc to cells in culture potently
resets their clock (6). Less is known of how Gc action and
the circadian clock interact in vivo, but adrenalectomy re-
duces the response time for animals to complete a phase
shift to a new lighting schedule (26, 27), and circadian liver
function has been linked to Gc action (7). We have
previously noted that therapeuticGcuse in animalmodels
of lung inflammationwasdifferentially effectiveby timeof
day, andat amolecular level,we identifieda circuit linking
the circadian clock via Bmal1 and Rev-erba to regulation of
neutrophilic inflammation through the airway epithelial
GR (3, 28). However, in those studies, we did not distin-
guish between a circadian signal from the adrenal pro-
duction of corticosterone, and circadian control of the
ligand-activated GR.
Therefore, our initial studies dissociated the timing
signal in serum corticosterone, by using a clamp. That did
not alter thepatternofCXCL5productionorBAL immune
cell infiltration. GR itself may be directly regulated by the
circadian clock and independent of a rhythmic ligand
signal, perhaps through modification by CLOCK acetyl-
transferase activity (23) or protein interaction with the
cryptochrome transcription factors (8). Accordingly, we
moved to investigate the GR itself. Because corticosterone
can activate both the GR and the closely related MR, we
needed to establishwhich receptor to target.Weused lung
slice cultures and were able to see a marked clock phase
shift with corticosterone and also with GSK67 and 69, 2
nonsteroidal GR agonists with very high potency and
specificity (21). Importantly,RU486wasable toantagonize
the GSK67/69 effects, but the MR antagonist had no effect
on corticosterone-induced resetting. Therefore, we tar-
geted deletion of the GR to the airway epithelium (Ccsp-
GR2/2).Despite the crucial role ofGR in lungdevelopment
and the effects ofGR loss inother lungcell populations (29),
micewere born in the expectedMendelian ratio and lacked
apparent lung pathology. We saw no change in the circa-
dian rhythm of LPS-induced neutrophilic inflammation,
but strikingly, we did abolish the rhythm in CXCL5. That
discord between neutrophil chemokine and neutrophil
influx was surprising, given that CXCL5 is the dominant
regulator of neutrophil influx to the alveolar space in this
model (30) and is strikingly different to the phenotype seen
in Ccsp-Bmal12/2 animals, where both CXCL5 and neu-
trophil influx lost oscillation with greatly increased pro-
duction of CXCL5 along with elevated pulmonary
neutrophilia (3) (Fig. 8). This reveals that epithelial GR is
required to transmit the time of day signal to Cxcl5
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Figure 6. Airway epithelium-speciﬁc GR loss affects gene
expression during homeostasis. RNA-sequencing from laser-
microdissected distal bronchiolar epithelial cells at ZT14. A)
Volcano plot of gene expression in bronchiolar epithelial cells
from Ccsp-GR2/2 mice relative to GRWT littermate controls. B)
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TABLE 1. Analysis of biologic pathways affected by epithelium-speciﬁc
GR loss
GO term P
Response to hypoxia 1.5E24
Lipid metabolic process 6.2E24
Negative regulation of inﬂammatory process 5.7E23
Positive regulation of transcription from RNA
PolII promoter
7.8E23
Cellular response to TNF 1.1E22
Cellular response to cyclohexamide 1.2E22
Inﬂammatory response 1.4E22
Gene Ontology (GO; http://www.geneontology.org/)term biologic
pathway–enrichment analysis of differentially expressed genes in distal
bronchiolar epithelial cells harvested at ZT14 from Ccsp-GR2/2 mice
and GRWT littermate controls (see Fig. 6A for volcano plot of gene
expression).
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expression but that additional pathways and factors are
operating to gate neutrophil infiltration to the lung.
It is becoming increasingly apparent that leukocyte
trafficking to tissues is under rhythmic regulation at mul-
tiple levels (31, 32), and neutrophil mobility is no excep-
tion. Neutrophil content in the bloodstream peaks at ZT5,
potentially providing a larger pool of circulating cells for
chemokine signals to reach if inflammatory stimuli are
administered at the start of the day (reviewed in Scheier-
mann et al. 33). However, neutrophils also age in the cir-
culation and up-regulate CXCR4, which drives rhythmic
homing to the bone marrow (34). In addition, neutrophil
function is not necessarily in concordance with neutrophil
numbers. We have previously reported that the up-
regulation of neutrophil influx in mice lacking a clock in
the pulmonary epithelium (Ccsp-Bmal12/2) does not con-
fer an advantage in bacterial clearance after Streptococcus
pneumoniae infection (3). Here,we also report no change in
total BAL protein concentrationswith neutrophil number,
indicating that rhythmic changes in neutrophilia are not
associated with rhythmic changes in general lung perme-
ability in thismodel.That is interestingbecause lung injury
after LPS inhalation was previously shown to be neutro-
phil dependent (35). Neutrophils may, therefore, also ex-
hibit temporal changes in their sensitivity to chemokine
signals and their effector functions, independent of their
number in circulation or in the alveolar space.
Because our Ccsp-GR2/2 transgenic mice serve as an
excellent tool for studying the role of GR in the airway
epithelium, we tested a therapeutic application of Dex.
Surprisingly, Dex is still anti-inflammatory with many
classic inflammatory genes, such as Il6 and Cxcl1, sup-
pressed in both WT and Ccsp-GR2/2 mice. In a broader
panel of 248 genes, Cxcl5 showed a genotype effect, con-
sistent with the pulmonary epithelium being a major
source of this Gc-repressed chemokine. However, addi-
tional neutrophil chemoattractants, suchasCxcl1 (KC)and
Cxcl2 (MIP-2), along with the receptors Cxcr1 and Cxcr2
were unaffected by loss of epithelial GR, and these were
comparably affected by Dex treatment. The colony-
stimulating factors G-CSF (Csf3) and GM-CSF (Csf2),
which regulate chemokine production and neutrophil
survival and accumulation in the airways (36–38), were
also unaffected by genotype. These factors are produced
by multiple cell types within the lung and show that our
targeting of the bronchial epithelial cells results in specific
changes in gene expression in the nebulized LPS model
without significant effects upon chemokine production in
the broader environment. It has recently been shown that
GR agonism can have differential effects in the lung
depending upon cell type and location and that endoge-
nous Gcs, acting as partial agonists, can inhibit the effects
of synthetic full agonists, such as Dex (39). Therefore, the
selective ablation of the GR in a subset of epithelial cells
may not have a significant effect upon a complex and
broad response, such as innate inflammation but, instead,
reveals thevery specific natureofGR regulationofCxcl5 in
the bronchial epithelial cell and highlights the dominant
role of the clock in these cells driving rhythmic physiology
and pathology in the lung (3, 19, 28).
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Figure 7. LysM-GR2/2 mice retain time of day variation in response to nebulized LPS and Dex sensitivity. GRWT and LysM-GR2/2
mice (median age, 12 wk) were exposed to nebulized LPS at the indicated time points and culled 5 h later. A) Quantiﬁcation of
total cells (left) and neutrophils (right) in BAL ﬂuid. B) Concentrations of CXCL5 (left) and total protein (right) in BAL. C)
Concentrations of IL-6 (left) and TNF-a (right) in BAL. D) The intraperitoneal injection of Dex (1 mg/kg) or saline (vehicle)
took place 1 h before LPS exposure at CT0. BAL was collected 5 h after LPS challenge, and total cells (left) and neutrophils
(right) were quantiﬁed. For all panels, n = 7–10; data were analyzed with 2-way ANOVA and Sidak’s multiple comparisons test
within genotypes. Data represent means 6 SE. **P , 0.01, ***P , 0.001.
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Figure 8. The gated LPS response. WT: Upon stimulation with LPS, inﬂammatory signaling pathways in the lung are engaged,
resulting in production of proinﬂammatory chemokines and neutrophil inﬂux through the pulmonary circulation (42, 43). In
WT animals, the clock regulates access to modulatory regions of chromatin, including an enhancer region in the Cxcl5 sequence
to which GR has been shown to bind with inhibitory effects upon transcription. At CT12, GR binding is permitted, and cell inﬂux
is suppressed relative to the challenge at CT0. A strong signal (CXCL5) combined with more neutrophils in the circulation
during the day (34) leads to an oscillation in inﬁltrating cell count (3). Cxcl52/2: CXCL5 predominates in driving neutrophil
inﬂux to the alveolar space in the nebulized LPS model (30). Mice can no longer produce Cxcl5 upon LPS stimulation, resulting
in low numbers of invading neutrophils at both time points. Some cells are still found in lavage ﬂuid, indicating successful
migration without a CXCL5 signal (3). Ccsp-Bmal12/2: Without Bmal1 in the bronchial epithelial cells, the inhibitory binding of
GR no longer occurs at CT12 and gating of CXCL5 production is lost. Production of CXCL5 is enhanced and increased
neutrophilia occurs at both time points without a day/night variation in inﬁltrating cell number (3). Ccsp-GR2/2: Without GR in
the bronchial epithelial cells, the inhibitory binding of GR no longer occurs at CT12, and gating of CXCL5 production is lost
despite the presence of an intact circadian clock. However, an intact oscillation in cell inﬂux remains. A nonrhythmic signal
(CXCL5), combined with oscillations in neutrophil count in the bloodstream (34), still results in an oscillation in inﬁltrating cell
count.
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Because airway macrophages are the other major cell
sensing and responding to pathogens entering the lung,
we also created mice that lacked the macrophage GR
(LysM-GR2/2). Again, we were surprised to see a very
minor phenotype reaction, either in response to in-
flammatory challenge or anti-inflammatory Dex treat-
ment. The retention of Dex sensitivity in our studies
differs from the reports of Bhattacharyya et al. (40) and of
Vettorazzi et al. (41), who found an impaired anti-
inflammatory response to Dex in LysM-GR2/2 mice. GR
inhibition of macrophage p38 stress-activated protein ki-
nase signalingwas shown tobe crucial for survival inLPS-
induced sepsis (40). In another model, a circuit was
identified that required macrophage Gc signaling to
prime local induction of sphingosine kinase 1 (SphK1) in
adjacent endothelial cells (41). The major difference be-
tween these 2 studies, which showed a requirement for
macrophage GR in regulating the inflammatory reaction,
and our study, which suggests that macrophage GR ac-
tionwasdispensable,was themodeofLPSadministration
and the severity of the challenge. In our nebulized LPS
model, there isminimal systemic response, and, therefore,
the absence of GR within the circulating myeloid cell
population was not tested, in contrast to the 2 earlier
studies, in which a significant systemic effect was amajor
feature of themodel. Our data suggest that, in the context
of a localized pulmonary inflammation, Gcs can mediate
anti-inflammatory effects acting through multiple cell
types, with sufficient redundancy to compensate for loss
in 1 cell type alone.
In summary, althoughbronchial epithelialGR is required
for rhythmic pulmonary Cxcl5 expression, loss of bronchial
epithelial GR does not impair the rhythmic variation in
pulmonary neutrophilic inflammation that we have pre-
viously characterized. Therefore, wewere able to dissociate
theclockcontrolofCXCL5fromclockcontrolofneutrophilic
infiltration. In our model of acute, localized pulmonary in-
flammation, the epithelial GRwas not required for the anti-
inflammatory action of therapeutically administered Dex,
suggesting additional cell types mediate that important ef-
fect. Further analysis of the myeloid lineage GR also
revealedasurprisinglymildphenotypewithminimaleffects
on lung inflammation and its therapeutic inhibition byDex.
Taken together, our studies reveal that neither airway epi-
thelial nor macrophage GR is required for Dex-mediated
suppressionofnebulizedLPS-inducedacute lung injury.
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